Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Receivables (2023 - 2025)

Adagio Medical Holdings has reported Receivables over the past 3 years, most recently at $1000.0 for Q1 2025.

  • Quarterly Receivables changed N/A to $1000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Mar 2025, changed N/A year-over-year, with the annual reading at $35000.0 for FY2024, 50.7% down from the prior year.
  • Receivables was $1000.0 for Q1 2025 at Adagio Medical Holdings, down from $35000.0 in the prior quarter.
  • Over five years, Receivables peaked at $90000.0 in Q3 2024 and troughed at $1000.0 in Q1 2025.
  • The 3-year median for Receivables is $53000.0 (2023), against an average of $49250.0.
  • The largest YoY upside for Receivables was 50.7% in 2024 against a maximum downside of 50.7% in 2024.
  • A 3-year view of Receivables shows it stood at $71000.0 in 2023, then plummeted by 50.7% to $35000.0 in 2024, then plummeted by 97.14% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADGM's Receivables are $1000.0 (Q1 2025), $35000.0 (Q4 2024), and $90000.0 (Q3 2024).